No updates on the Optomed Aurora AEYE FDA clearance process
Optomed Plc Stock Exchange Release 29 April 2024 at 13:20, Helsinki No updates on the Optomed Aurora AEYE FDA clearance process Optomed is together with its partner AEYE Health in the process of obtaining a clearance for the AI fundus camera Optomed Aurora AEYE. At this stage, Optomed does not have any new information regarding the FDA clearance process. Optomed will update market as new information becomes available. Optomed Plc Further enquiries Juho Himberg, CEO, juho.himberg@optomed.com Optomed in Brief Optomed is a Finnish medical